Virtus Biotech ETF
14 hedge funds and large institutions have $5.16M invested in Virtus Biotech ETF in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
34% more capital invested
Capital invested by funds: $3.85M → $5.16M (+$1.31M)
8% more funds holding
Funds holding: 13 → 14 (+1)
4.73% more ownership
Funds ownership: 18.71% → 23.44% (+4.7%)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JCM
Jag Capital Management
St Louis,
Missouri
|
+$251K |
| 2 |
Morgan Stanley
New York
|
+$46.8K |
| 3 |
LPL Financial
San Diego,
California
|
+$20.6K |
| 4 |
JP Morgan Chase
New York
|
+$5.6K |
| 5 |
IFG
Independent Financial Group
San Diego,
California
|
+$3.61K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$273K |
| 2 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$238K |
| 3 |
Goldman Sachs
New York
|
-$162K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$91.7K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$84.9K |
BBP Hedge Fund Activity: Q3 2024 in Review
14 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q3 2024, worth a combined $5.16M — up 34% from $3.85M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BBP positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Jag Capital Management, opening a new position worth an estimated $251K. The largest seller was Citadel Advisors, exiting entirely with an estimated $273K sold.
- 14 institutional investors held Virtus Biotech ETF (BBP) as of Q3 2024, up from 13 in Q2 2024.
- Funds reported $5.16M of Virtus Biotech ETF stock for Q3 2024, up 34% quarter-over-quarter.
- 3 funds opened new Virtus Biotech ETF positions in Q3 2024 and 2 closed out, a net change of +1 holder.
- The largest Virtus Biotech ETF buyer in Q3 2024 was Jag Capital Management, an estimated $251K added.
- The largest Virtus Biotech ETF seller in Q3 2024 was Citadel Advisors, an estimated $273K sold.
Based on aggregated 13F filings for Q3 2024.